Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Icu Medical (ICUI) over the last 10 years, with Q3 2025 value amounting to $19.8 million.

  • Icu Medical's Interest Expenses fell 1975.04% to $19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.4 million, marking a year-over-year decrease of 1370.48%. This contributed to the annual value of $858000.0 for FY2021, which is 5105.53% down from last year.
  • According to the latest figures from Q3 2025, Icu Medical's Interest Expenses is $19.8 million, which was down 1975.04% from $20.5 million recorded in Q2 2025.
  • In the past 5 years, Icu Medical's Interest Expenses ranged from a high of $24.7 million in Q3 2024 and a low of $161000.0 during Q1 2021
  • Over the past 5 years, Icu Medical's median Interest Expenses value was $20.2 million (recorded in 2025), while the average stood at $15.8 million.
  • As far as peak fluctuations go, Icu Medical's Interest Expenses crashed by 7885.86% in 2021, and later skyrocketed by 1050000.0% in 2022.
  • Icu Medical's Interest Expenses (Quarter) stood at $366000.0 in 2021, then surged by 4765.57% to $17.8 million in 2022, then surged by 35.75% to $24.2 million in 2023, then increased by 2.1% to $24.7 million in 2024, then fell by 19.75% to $19.8 million in 2025.
  • Its last three reported values are $19.8 million in Q3 2025, $20.5 million for Q2 2025, and $22.0 million during Q1 2025.